Featured Research

from universities, journals, and other organizations

Help for a scarred heart: Scarring cells turned to beating muscle

Date:
February 12, 2014
Source:
University of Michigan
Summary:
Poets and physicians know that a scarred heart cannot beat the way it used to, but the science of reprogramming cells offers hope -- for the physical heart, at least.

Human heart (stock illustration). A team of University of Michigan biomedical engineers has turned cells common in scar tissue into colonies of beating heart cells. Their findings could advance the path toward regenerating tissue that's been damaged in a heart attack.
Credit: unlim3d / Fotolia

Poets and physicians know that a scarred heart cannot beat the way it used to, but the science of reprogramming cells offers hope--for the physical heart, at least.

A team of University of Michigan biomedical engineers has turned cells common in scar tissue into colonies of beating heart cells. Their findings could advance the path toward regenerating tissue that's been damaged in a heart attack.

Previous work in direct reprogramming, jumping straight from a cell type involved in scarring to heart muscle cells, has a low success rate. But Andrew Putnam, an associate professor of biomedical engineering and head of the Cell Signaling in Engineered Tissues Lab, thinks he knows at least one of the missing factors for better reprogramming.

"Many reprogramming studies don't consider the environment that the cells are in -- they don't consider anything other than the genes," he said. "The environment can dictate the expression of those genes."

To explore how the cells' surroundings might improve the efficiency of reprogramming, Yen Peng Kong, a post-doctoral researcher in the lab, attempted to turn scarring cells, or fibroblasts, into heart muscle cells while growing them in gels of varying stiffness. He and his colleagues compared a soft commercial gel with medium-stiffness fibrin, made of the proteins that link with platelets to form blood clots, and with high-stiffness collagen, made of structural proteins.

The fibroblasts came from mouse embryos. To begin the conversion to heart muscle cells, Kong infected the fibroblasts with a specially designed virus that carried mouse transgenes -- genes expressed by stem cells.

Fooled into stem cell behavior, the fibroblasts transformed themselves into stem-cell-like progenitor cells. This transition, which would be skipped in direct reprogramming, encouraged the cells to divide and grow into colonies rather than remaining as lone rangers. The tighter community might have helped to ease the next transition, since naturally developing heart muscle cells are also close with their neighbors.

After seven days, Kong changed the mixture used to feed the cells, adding a protein that encourages the growth of heart tissue. This helped push the cells toward adopting the heart muscle identity. A few days later, some of the colonies were contracting spontaneously, marking themselves out as heart muscle colonies.

The transition was particularly successful in the fibrin and fibrin-collagen mixes, which saw as many as half of the colonies converting to heart muscle.

The team has yet to discover exactly what it is about fibrin that makes it better for supporting heart muscle cell. While most materials either stretch or weaken under strain, fibrin gets harder. Putnam wonders whether the fibrin was successful because heart muscles expect a material that toughens up when they contract.

A number of challenges stand between current techniques and healing hearts by reprogramming scar tissue. Researchers need an effective way to wake up the stem cell properties without the use of potentially risky viruses. Also, the scar tissue needs to be altered so that cell reprogramming -- or even new heart cells prepared outside the body -- will take well.


Story Source:

The above story is based on materials provided by University of Michigan. Note: Materials may be edited for content and length.


Journal Reference:

  1. Yen P. Kong, Bita Carrion, Rahul K. Singh, Andrew J. Putnam. Matrix identity and tractional forces influence indirect cardiac reprogramming. Scientific Reports, 2013; 3 DOI: 10.1038/srep03474

Cite This Page:

University of Michigan. "Help for a scarred heart: Scarring cells turned to beating muscle." ScienceDaily. ScienceDaily, 12 February 2014. <www.sciencedaily.com/releases/2014/02/140212132903.htm>.
University of Michigan. (2014, February 12). Help for a scarred heart: Scarring cells turned to beating muscle. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/02/140212132903.htm
University of Michigan. "Help for a scarred heart: Scarring cells turned to beating muscle." ScienceDaily. www.sciencedaily.com/releases/2014/02/140212132903.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins